Page - 83 - in Cancer Nanotheranostics - What Have We Learnd So Far?
Image of the Page - 83 -
Text of the Page - 83 -
Conniotet al. Nanocarriers for immunecell targetingand tracking
The use of targeted nanoplatforms for this purpose enables
amore specific interactionwith the intended target, withmin-
imal interference to the biological system (Ballou et al., 2004).
Additionally, nanocarriersmay be functionalized with single or
multiple ligands, which may be important for the design of
complex experiments. The targeting of ligandsmay enhance the
selective recognition of the nanodelivery systems by cells, facili-
tatingtheirendocytosis.Thiswillallownanosystemstobeusedas
non-invasive localization,monitoring andassessmentplatforms,
for instance, for site-specific intracellular characterizations and
real-timetracking(Ruanetal., 2007).
Fluorescenceimagingtechniques
Fluorescence imaging is an optical imaging method based on
the excitation/emissionofmolecules (Cai andChen, 2007). The
useoffluorescentmolecularprobes—asfluorescentdyesandflu-
orescent proteins—has been widely applied in the labeling of
biomolecules, cellsandtissues.Althoughtheseprobesarealready
used in vivo, for instance in retinal angiography and visualiza-
tionof arteries, they areunsuitable for real-time imaging assays,
regarding their low photostability and sensitivity at the cellular
andmolecular levels (Santra andMalhotra, 2011). The applica-
tion of fluorophores in real-time in vivo imaging has also been
limited by the high absorption of optical signal by tissues and
body fluids in theUVand visiblewavelength. The light scatter-
ing caused by tissues that attenuate the optical signal and the
tissue auto-fluorescence that influences the background signal is
alsoa limitation(SantraandMalhotra,2011).Additionally, some
fluorescent probes may be toxic for cells and body (Li et al.,
2013). Several NP-based strategies have been proposed to over-
come the limitations of fluorescent dyes for real-time in vivo
imaging (SupplementaryMaterial) (Santra andMalhotra, 2011;
Wangetal., 2013b).
Fluorescent-labeled NPs are more stable in the body and
increase the detection sensitivity andphotostability. In the same
platforms, a great number of probe molecules can be incor-
porated, in opposite to a single conventional molecule. Also,
in NPs, fluorescent dyes can be protected from quenching and
degradation(SantraandMalhotra,2011;Wangetal., 2013b).
The most extensively studied nanosystems for fluorescence
imaging are quantum dots (QDs) (Cai and Chen, 2007), inor-
ganicfluorescentNPs that canbebasedonmetallic or semicon-
ductormaterials, such as CdSe and CdTe (Ballou et al., 2004).
As reviewed by Cai and Chen, in ideal conditions, QDs can
have better properties than organic fluorescence probes. These
includehigh resistance todegradationandphotobleaching, high
quantum yields, highmolar extinction coefficients, continuous
absorption spectra covering fromUVtonear-infrared, longflu-
orescence lifetimes (>10 ns), narrow emission spectra and very
longeffectiveStokes shifts (Cai andChen,2007).QDshavebeen
usedforinnumerousapplications,fromcelltracking(Vouraetal.,
2004) tomapping of sentinel lymphnodes (Ballou et al., 2007).
QDs can be used to identify several ligands in the same exper-
iment, using multiple colors and intensities to detect different
structures(Ballouetal.,2004).ThepotentialuseofDC-targeting
QDs as both fluorescent NPs for in vivo and in vitro imaging,
and antigen-delivery system has also been investigated. In this study, it was proved that QDs display promising properties for
combinedprimingandimmunoimagingofDC(Senetal.,2008).
Functionalization andmodifications of the surface ofQDswith
PEGchainsand ligands foractive targeting, suchaspeptides and
antibodies, havebeenunder research to improve the application
of thesenanosystems in thebiomedical field (Ballou et al., 2007;
Cai and Chen, 2007). QD conjugates are already commercially
available for immunospecific labeling (Ballouet al., 2004).Thus,
thedevelopmentofmultifunctionalnanoplatformsholds agreat
promise for the futureofbiomedicine, since itwill bepossible to
combine simultaneouslybothdiagnosis and therapy in the same
nanostructure(Kimetal., 2008a).
Several other groups have suggested the use of silica-based
NPs (siNPs) as an interesting strategy toperform imaging assays
using fluorescence (Santra et al., 2005; Kim et al., 2008a;Wang
et al., 2013b). siNPs have been used for high sensitive and spe-
cific in situ labeling and tracking of cell surface receptors (He
et al., 2004, 2007).Relyingon theaffinityof antigen-antibodyor
ligand-receptor interactions,NPswere functionalizedwith anti-
bodies and ligands andappliedas an immunediagnosticmethod
(He et al., 2002). siNPs have also been used as a non-invasive
tool for intracellular labeling, trackingandsensing in livingcells,
contributing with novel information about dynamic biological
processes of subcellular structures, such as lysosomes and endo-
somes (Shi et al., 2010). Finally, siNPs were applied to better
understand the biodistribution and fate of NPs, in vivo (Wang
etal., 2013b).
Molecular imagingtechniques
The key role of immune cells in the development of future
immunotherapeutic approaches against chronic pathologies,
mainly cancer diseases, has fostered the design and optimiza-
tionofdifferentreal-timeimagingtechniques,avoidingtheclassic
exvivohistologicanalysis (Kircheret al., 2011;AhrensandBulte,
2013;LiuandLi,2014). Infact,mostof the informationobtained
for immune cell tracking has arisen from optical and confocal
microscopyandflowcytometry.Two-photonmicroscopyallowed
theobservationofdifferent immunecells in theirbiologicalenvi-
ronment at real time (Progatzky et al., 2013). However, despite
being a powerful tool to observe these highly motile cells and
characterizetheir interactionwithnativeenvironment, this imag-
ing technique is unsuitable fordetectionofdeeper events due to
tissueopacity (Dzhagalovetal., 2012).
Bioluminescence imaging techniques, on the other hand,
enable deeper tissue penetrations while tracking immune cells
in vivo. Even though, it is oneof themost commonlyused tech-
niques for immune cell tracking in vivo, allowing whole-body
non-invasive tomography. This technique is only useful for pre-
clinical studies in small animals, due to the limits related to the
attenuationof light in tissues (Kircheretal., 2011).
Allnear-infrared(NIR)multiphotonmicroscopymethodsare
potential techniques for deep tissue imaging but further studies
are needed to better characterize the capabilities of these NIR-
excitation techniques and background reduction (Joshi et al.,
2013).
Magnetic resonance imaging (MRI), ultrasound, positron
emission tomography (PET) (Yaghoubi et al., 2009), single
Frontiers inChemistry | ChemicalEngineering November2014 |Volume2 |Article105 | 83
Cancer Nanotheranostics
What Have We Learnd So Far?
- Title
- Cancer Nanotheranostics
- Subtitle
- What Have We Learnd So Far?
- Authors
- João Conde
- Pedro Viana Baptista
- Jesús M. De La Fuente
- Furong Tian
- Editor
- Frontiers in Chemistry
- Date
- 2016
- Language
- English
- License
- CC BY 4.0
- ISBN
- 978-2-88919-776-7
- Size
- 21.0 x 27.7 cm
- Pages
- 132
- Keywords
- Nanomedicine, Nanoparticles, nanomaterials, Cancer, heranostics, Immunotherapy, bioimaging, Drug delivery, Gene Therapy, Phototherapy
- Categories
- Naturwissenschaften Chemie